AARD
Aardvark Therapeutics, Inc. Common Stock
NASDAQ: AARD · HEALTHCARE · BIOTECHNOLOGY
$5.21
-6.80% today
Updated 2026-04-29
Market cap
$113.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$3 – $18
Volume
0.3M
Aardvark Therapeutics, Inc. Common Stock (AARD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 6
Last 6 quarters
Avg EPS surprise
+26.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.8%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-12.9%
2026-03-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-06 | $0.00 | +100.0% | $4.30 | $4.04 | -6.0% |
| 2026-03-24 | $-0.81 | +2.1% | $4.07 | $3.54 | -12.9% |
| 2025-11-13 | $-0.75 | +2.6% | $10.73 | $9.92 | -7.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.80 | $0.00 | +100.0% | — | — |
| 2025-12-31 | $-0.83 | $-0.81 | +2.1% | — | — |
| 2025-09-30 | $-0.77 | $-0.75 | +2.6% | — | — |
| 2025-06-30 | $-0.68 | $-0.66 | +2.6% | — | — |
| 2025-03-31 | $-0.70 | $-0.71 | -1.4% | — | — |
| 2024-12-31 | $-0.20 | $-0.44 | -117.5% | — | — |
Frequently asked questions
Has Aardvark Therapeutics, Inc. Common Stock beaten earnings estimates?
Aardvark Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 4 of its last 6 quarterly reports, with an average EPS surprise of +26.8% over the last 4 quarters.
How does AARD stock react to earnings?
AARD stock has moved an average of -8.8% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.